Suppr超能文献

肝硬化患者肝细胞癌根治性肝切除的疗效

Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis.

作者信息

Elshaarawy Omar, Aman Aya, Zakaria Hazem Mohamed, Zakareya Talaat, Gomaa Asmaa, Elshimi Esam, Abdelsameea Eman

机构信息

Department of Hepatology, Gastroenterology and Liver Transplantation, National Liver Institute, Menoufia University, Shebine Elkom 32511, Menoufia, Egypt.

Department of Hepatobiliary Pancreatic Surgery, National Liver Institute, Menoufia University, Shebine Elkom 32511, Menoufia, Egypt.

出版信息

World J Gastrointest Oncol. 2021 May 15;13(5):424-439. doi: 10.4251/wjgo.v13.i5.424.

Abstract

BACKGROUND

Given the poor synthetic function of cirrhotic liver, successful resection for patients with hepatocellular carcinoma (HCC) necessitates the ability to achieve resections with tumor free margins.

AIM

To validate post hepatectomy liver failure score (PHLF), compare it to other established systems and to stratify risks in patients with cirrhosis who underwent curative liver resection for HCC.

METHODS

Between December 2010 and January 2017, 120 patients underwent curative resection for HCC in patients with cirrhosis were included, the pre-operative, operative and post-operative factors were recorded to stratify patients' risks of decompensation, survival, and PHLF.

RESULTS

The preoperative model for end-stage liver disease (MELD) score [odds ratio (OR) = 2.7, 95%CI: 1.2-5.7, = 0.013], tumor diameter (OR = 5.4, 95%CI: 2-14.8, = 0.001) and duration of hospital stay (OR = 2.5, 95%CI: 1.5-4.2, = 0.001) were significant independent predictors of hepatic decompensation after resection. While the preoperative MELD score [hazard ratio (HR) = 1.37, 95%CI: 1.16-1.62, < 0.001] and different grades of PHLF (grade A: HR = 2.33, 95%CI: 0.59-9.24; Grade B: HR = 3.15, 95%CI: 1.11-8.95; Grade C: HR = 373.41, 95%CI: 66.23-2105.43; < 0.001) and HCC recurrence (HR = 11.67, 95%CI: 4.19-32.52, < 0.001) were significant independent predictors for survival.

CONCLUSION

Preoperative MELD score and tumor diameter can independently predict hepatic decompensation. While, preoperative MELD score, different grades of PHLF and HCC recurrence can precisely predict survival.

摘要

背景

鉴于肝硬化肝脏的合成功能较差,肝细胞癌(HCC)患者成功切除肿瘤需要能够实现切缘无肿瘤的切除。

目的

验证肝切除术后肝功能衰竭评分(PHLF),将其与其他既定系统进行比较,并对接受根治性肝切除治疗HCC的肝硬化患者的风险进行分层。

方法

2010年12月至2017年1月,纳入120例接受肝硬化患者HCC根治性切除的患者,记录术前、术中和术后因素,以对患者失代偿、生存和PHLF的风险进行分层。

结果

术前终末期肝病模型(MELD)评分[比值比(OR)=2.7,95%置信区间:1.2 - 5.7,P = 0.013]、肿瘤直径(OR = 5.4,95%置信区间:2 - 14.8,P = 0.001)和住院时间(OR = 2.5,95%置信区间:1.5 - 4.2,P = 0.001)是切除术后肝失代偿的显著独立预测因素。而术前MELD评分[风险比(HR)=1.37,95%置信区间:1.16 - 1.62,P < 0.001]、不同等级的PHLF(A级:HR = 2.33,95%置信区间:0.59 - 9.24;B级:HR = 3.15,95%置信区间:1.11 - 8.95;C级:HR = 37,3.41,95%置信区间:66.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1f6/8131904/77240ef3cfe6/WJGO-13-424-g001.jpg

相似文献

引用本文的文献

本文引用的文献

8
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验